International ASET Inc. is proud to present Dr. Vladimir Muzykantov as the Congress Co-Chair for The World Congress on New Technologies (NewTech 2015).

Vladimir Muzykantov MD, PhD
Professor of Pharmacology and Medicine, University of Pennsylvania
muzykant@mail.med.upenn.edu
Website

Vladimir Muzykantov obtained his M.D. in Internal Medicine in 1980 from Moscow Medical School and Ph.D. (Biochemistry, 1985) from Russian National Cardiology Research Center, where he worked in 1980-1993. He joined University of Pennsylvania in 1993. Since early eighties, his career is dedicated to research, educational and translational efforts in the area of vascular targeting of drug carriers, biotherapeutics and imaging probes. He described many new findings in the areas of novel molecular targets for drug delivery and nanocarriers targeted to vascular endothelium including first reports on induced endocytosis of nanocarriers anchored to normally non-internalized cellular receptors, targeted intracellular delivery of semi-permeable nanocarriers encapsulating antioxidant enzymes, paradoxical enhancement of targeting by collaborating antibodies and enhancement of targeting selectivity by controlled reduction on nanocarrier avidity. Among other findings, he devised a paradigm-shifting strategy and biotechnology platform for new class of recombinant mutant protein pro-drugs using blood cells as natural carriers for targeted drug delivery. He has published ~170 peer reviewed papers on drug delivery in the leading journals including Nature Biotechnology, PNAS, Blood and ACS Nano and edited a book "Biomedical Aspects of Drug Targeting" (Kluwer Academic Press, 2003). Honors include the American Heart Association Established Investigator Award and Bugher Stroke Award, Chairing Transatlantic Conference on Imaging Target Molecular Signatures in Lungs (Luzerne, 2009) and the Gordon Conference on Drug Carriers (2012), Dr. Jane Glick's Graduate Teaching Award (2013).